LPAR6 and breast carcinoma: Moreover, three cohorts (GSE19615, GSE9195 and GSE11121) of breast cancer demonstrated that higher expression level of LPAR6 was correlated with a better prognostic potential of DMFS (Supplementary Figure S1E–G).